Nelmastobart in Combination With Tas-102 and Bevacizumab in Recurrent/Metastatic Colorectal Cancer
Clinical trial NCT07656038 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07656038
- Sponsor
- STCube, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-30
- Primary completion
- 2028-07-31
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.